Viewing Study NCT04392505

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-05-27 @ 12:01 AM
Study NCT ID: NCT04392505
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-29
First Post: 2020-05-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study
Sponsor: Oslo University Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Non Small Cell Lung Cancer View
None Non Small Cell Lung Cancer Stage III View
None NSCLC View
None NSCLC, Stage III View
Keywords: